ArticleJournal of cancer research and clinical oncology2021

Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor.

Aldo Prawira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.